Page 153 - PJ MED OPS Handbook 8th Ed
P. 153

®
                                                   ®
                         Acetaminophen – PO (Tylenol ), IV (Ofirmev )
            •  Description: non-narcotic analgesic and antipyretic, blocks generation of pain impulses in the
              CNS by preventing sensitization of pain receptors
            •  Indications: mild pain or fever, febrile reactions from blood transfusions
            •  Dose: 325–650mg PO q4–6hr; or 1g PO/IV q6–8hr
                Contraindications: Individuals with hypersensitivity to drug or chronic liver damage. Caution
              in use with patients diagnosed with a history of excess alcohol use.
            •  Side-effects: rash, urticaria
            •  Adverse reactions: hemolytic anemia, liver damage

                                  Acetazolamide (Diamox)
               GROUNDING medication for personnel on flight status
                Waiver: If approved by MAJCOM protocol – Combat Rescue Officers, Pararescue, Combat
         Control, and TAC-P are waived (No DNIF) upon completion of 3 day ground test.
            •  Description: non-diuretic antihypertensive (carbonic anhydrase inhibitor)
            •  Indications: Prevention and/or amelioration of symptoms associated with acute mountain sick-
              ness in climbers attempting rapid ascent and/or those who are very susceptible to acute moun-
              tain sickness despite gradual ascent. For maximum benefit begin regimen 7 days prior to as-
              cent. Of minimal benefit in Rx of AMS, HACE, or HAPE. Treatment of acute high altitude illness.
            •  Dose (Human):
                 ○ 125mg bid: prevention of Acute Mountain Sickness, 24 hours prior to ascent, continuing for
                 48 hours after ascent. Prevention and/or amelioration benefits are nominal once ascent has
                 commenced. If the 500mg sustained release tablet is used, dose is 500mg q24hr.
                 ○ 250mg bid: treatment of existing Acute Mountain Sickness
            •      K9 dose: 250mg bid 24 hours prior to ascent, continuing for 48 hours after ascent. If the
              500mg sustained release tablet is used, dose is 500mg q24hr.
                Contraindications: sulfa allergy, pregnancy
            •  Side-effects: paresthesias in extremities (very common in fingers/toes); hearing dysfunction/
              tinnitus; loss of appetite; taste alterations; polyuria; drowsiness; confusion; increased fluid
              intake is required with use of diamox: although diamox is not in the general drug class of
              “ diuretics”; it has diuretic effects and can result in serious dehydration unless great care is
              taken to maintain proper hydration.
            •  Adverse reactions: transient myopia; urticaria; melena; photosensitivity; convulsions

                                   Adenosine (Adenocard)
               GROUNDING medication for personnel on flight status.
            •  Description: antiarrhythmic agent
            •  Indications: Used to convert PSVT, WILL NOT convert atrial flutter, atrial fibrillation, or VT.
            •  Adult dose: 6mg rapid IV bolus (1–3 sec) followed by 10mL flush. Two additional doses of
              12mg can be administered following the same rapid push sequence.
            •  Pediatric dose: 0.1–0.2mg/kg IV rapid push, if IO up to 6mg
                Contraindications: 2nd/3rd degree AV block, sick sinus syndrome, pregnancy




                                                  Chapter 9.  Pararescue Drug Formulary  n  151
   148   149   150   151   152   153   154   155   156   157   158